Viewing Study NCT03241927


Ignite Creation Date: 2025-12-25 @ 5:18 AM
Ignite Modification Date: 2026-05-26 @ 9:25 PM
Study NCT ID: NCT03241927
Status: TERMINATED
Last Update Posted: 2020-11-23
First Post: 2017-08-02
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT)
Sponsor: Nina Bhardwaj
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pembrolizumab View
None NK Cell Exhaustion View
None PD-1 View
None Unresectable View
None Stage III View
None Stage IV View